Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Gastroenterology"
DOI: 10.1007/s00535-020-01679-7
Abstract: Background The interaction between T-cells/fatty acids involved in non-alcoholic fatty liver disease (NAFLD) and liver fibrosis progression is poorly understood. In this study, we conducted a comprehensive analysis of T-cell profiles of NAFLD patients to… read more here.
Keywords: liver fibrosis; fatty acids; cell profiles; nafld patients ... See more keywords
Increased levels of alpha-tocopherylquinone (α-TQ) demonstrate a higher vitamin E oxidation rate in non-alcoholic fatty liver disease (NAFLD) patients
Sign Up to like & getrecommendations! Published in 2018 at "Free Radical Biology and Medicine"
DOI: 10.1016/j.freeradbiomed.2018.04.403
Abstract: Hepatic lipid peroxidation is a key pathogenic event in the progression from NAFLD to the more severe inflammatory and fibrotic lesions of non-alcoholic steatohepatitis (NASH). This more advanced stage of the disease is a major… read more here.
Keywords: oxidation rate; oxidation; non alcoholic; vitamin oxidation ... See more keywords
Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-65940-y
Abstract: To date, there are few studies that have evaluated the prognostic impact of changes in abdominal obesity or weight on long-term adverse kidney outcomes in non-alcoholic fatty liver disease (NAFLD). We investigated the effect of… read more here.
Keywords: disease; ratio; non obese; nafld patients ... See more keywords
Therapeutic Potential of Artichoke in the Treatment of Fatty Liver: A Systematic Review and Meta-Analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of medicinal food"
DOI: 10.1089/jmf.2022.0025
Abstract: Nonalcoholic fatty liver disease (NAFLD) is a major chronic liver disease that can lead to liver cirrhosis, liver cancer, and death. Artichoke leaf extract (ALE) is well known in folk medicine for its hepatoprotective effect.… read more here.
Keywords: review; nafld patients; meta analysis; fatty liver ... See more keywords
MO463EVIDENCE OF MICROALBUMINURIA AND ESTIMATED GLOMERULAR FILTRATION RATE DECLINE AS CHRONIC KIDNEY DISEASE RISKS IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS: META-ANALYSIS OF COHORT STUDIES
Sign Up to like & getrecommendations! Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab090.0025
Abstract: Recent evidences showed an association between NAFLD and extrahepatic manifestations such as chronic kidney disease (CKD) although the result is still inconclusive. This study aims to measure the association of microalbuminuria and estimated glomerular filtration… read more here.
Keywords: cohort studies; egfr decline; nafld patients; decline ... See more keywords
Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome
Sign Up to like & getrecommendations! Published in 2023 at "Hepatology"
DOI: 10.1097/hep.0000000000000238
Abstract: Background and Aims: The prevalence of alcohol use disorder (AUD) and metabolic dysfunction-associated fatty liver disease (MAFLD) are increasing worldwide, leading to the increasing likelihood of both etiologies contributing to a patient’s liver disease. However,… read more here.
Keywords: use nafld; nafld patients; alcohol use; alcohol ... See more keywords
CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029347
Abstract: Abstract Patients with nonalcoholic fatty liver disease (NAFLD) have symptoms of a gut microbiota disorder with abnormal amino acid and glycolipid metabolism. This study was designed to analyze the characteristics of gut microbiota in patients… read more here.
Keywords: nafld patients; microbiota nafld; nafld; gut microbiota ... See more keywords
Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030527
Abstract: While patients with nonalcoholic fatty liver disease (NAFLD) continue to increase worldwide, few hematological biomarkers are helpful. This study examined the potential of small dense low density lipoprotein (sdLDL) as a noninvasive biomarker for NAFLD… read more here.
Keywords: patients nonalcoholic; liver; hepatic fibrosis; sdldl ... See more keywords
Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031437
Abstract: Background: Whether metformin is related to nonalcoholic fatty liver disease (NAFLD) is controversial. Our aim was to investigate the relationship between metformin and NAFLD that may predict the metformin potential of these lesions and new… read more here.
Keywords: nonalcoholic fatty; metformin nafld; effect; fatty liver ... See more keywords
Should Patients With NAFLD/NASH Be Surveyed for HCC?
Sign Up to like & getrecommendations! Published in 2019 at "Transplantation"
DOI: 10.1097/tp.0000000000002361
Abstract: Background Patients with nonalcoholic fatty liver disease (NAFLD) are at risk of developing hepatocellular carcinoma (HCC), but the magnitude of the association still needs to be determined to define the need for a specific surveillance… read more here.
Keywords: patients without; hcc; nafld patients; incidence ... See more keywords
Gamma-glutamyl transferase predicts pemafibrate treatment response in non-alcoholic fatty liver disease.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of gastroenterology and hepatology"
DOI: 10.1111/jgh.16222
Abstract: BACKGROUND AND AIM Pemafibrate, a selective peroxisome proliferator activated receptor α modulator, has been shown to improve liver function among nonalcoholic fatty liver disease (NAFLD) patients with dyslipidemia. The aim of this retrospective study is… read more here.
Keywords: fast score; ggt; fatty liver; nafld patients ... See more keywords